Graham Cooke

Graham Cooke is a clinician scientist and NIHR Professor of Infectious Diseases at the Wright-Fleming Institute of Imperial College London. He is best known for his work on viral hepatitis, particularly hepatitis C.

Early life and education

Educated at Watford Grammar School for Boys, he studied natural sciences and medicine at University of Cambridge. Later he undertook his doctoral studies with Adrian V. S. Hill at the Wellcome Center for Human Genetics, studying human genetic variation and its role in susceptibility to tuberculosis.

Research and career

After specialist training in London, Cooke was based at the Africa Centre for Health and Population Studies, Mtubatuba (now AHRI) before moving to Imperial College. His work has focused on HIV, tuberculosis and viral hepatitis.

COVID-19 During the COVID-19 pandemic, Cooke was an investigator on the REACT (Real-time Assessment of Community Transmission) programme, the largest study of consented individuals during the pandemic. The programme made important contributions to government policy and informed decisions on relaxation of national restrictions and vaccine delivery.

With Chris Toumazou, he led the development of the COVIDnudge diagnostic, implemented in the NHS in 2020.

Other roles He has advocated for access to affordable medicines. He became a member of the WHO committee for Selection and Use of Essential Medicines in 2015 and chairman in 2019. In 2021, he was appointed non-executive director and Deputy Chair of the Medicines and Healthcare products Regulatory Agency Board (MHRA).

Honours He is a Fellow of the Royal College of Physicians (2012), National Institute for Health and Care Research (NIHR) Research Professor (2017), Fellow of the Academy of Medical Sciences (2023).